We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Olympus

Manufactures optical and digital equipment for the healthcare and consumer electronics sectors, including endoscopy a... read more Featured Products: More products

Download Mobile App




Ultrasound Aspiration Needle Guides Lung Cancer Treatment

By HospiMedica International staff writers
Posted on 04 Nov 2021
A new endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) needle effectively gathers tissue samples critical for non-small cell lung cancer (NSCLC) treatment.

The Olympus (Tokyo, Japan) ViziShot 2 FLEX 19G EBUS-TBNA needle features a needle tip design with spiral laser cuts along the sides of the needle surface provide greater flexibility and angulation capabilities to sample targets in difficult-to-reach locations. More...
For pinpoint accuracy, the distal end is treated with spiral echogenic markings to optimize visualization of the needle tip on the ultrasound image. The enhanced visibility facilitates correct capsule-to-capsule technique to optimize sample collection.

A proprietary double-locking safety feature helps avoid accidental patient and personnel injury, as well as damage to the EBUS scope. The large inner lumen enables substantial tissue collection, with a 72% increase in inner surface over the 21-G needle and 144% increase over the 22-G, increasing success rates for collection of important markers such as epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK) and c-ros oncogene 1 (ROS-1). In immunotherapy treatment, it can also target inhibition of the cell death receptor (PD-1) or its ligand (PD-L1).

Results of a recent study showed that 58% of the specimens collected with the 19-G needle EBUS-TBNA contained more than 500 malignant cells, and 22% had 200-500 malignant cells. The success rates for marker testing stood at 90% for PD-L1 and EGFR, and 86% for ALK. There were no adverse effects on tissue analysis due to blood contamination, and no additional traumas were seen, when compared to smaller gauge needles. The study was published in the July 2021 edition of Journal of Bronchology and Interventional Pulmonology.

“We are very pleased to see the results showing the 19-G has a high success rate in testing for molecular markers and immune checkpoint inhibitor targets,” said Lynn Ray, vice president and general manager of the Global Respiratory Business Unit at Olympus. “Samples with a high number of tumor cells give the pathology team more to work with, which helps the oncology team make a timely diagnosis and gives them the information needed to provide personalized, targeted, lung cancer treatment.”

EBUS-TBNA is a procedure used in the diagnosis and staging of lung cancer, allowing physicians to visualize diseased tissue, lymph nodes, or lesions beyond the walls of the airways. Samples from parts of the lymph node that require further investigation can be taken using a specialized needle. The procedure has proved a less invasive and cost-effective method to diagnose and stage lung cancer.

Related Links:
Olympus


Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Heavy-Duty Wheelchair Scale
6495 Stationary
Newborn Hearing Screener
ALGO 7i
Infant Incubator
OKM 801
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.